Citation Impact
Citing Papers
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
2003 Standout
Differential Expression of the Angiogenic Factor Genes Vascular Endothelial Growth Factor (VEGF) and Endocrine Gland-Derived VEGF in Normal and Polycystic Human Ovaries
2003
Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration
1999
Polycystic Ovary Syndrome in Asian Women
2008
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters
2005
Formulation and Delivery Technologies for mRNA Vaccines
2020
Lipid nanoparticles for mRNA delivery
2021 Standout
HIF-1: Using Two Hands to Flip the Angiogenic Switch
2000 StandoutNobel
Total salpingectomy during abdominal hysterectomy: Effects on ovarian reserve and ovarian stromal blood flow
2007
Angiogenesis in ovarian follicular and luteal development
2000
Prospective longitudinal cohort study on cumulative 5-year delivery and adoption rates among 1338 couples initiating infertility treatment
2008
Premature ageing in mice expressing defective mitochondrial DNA polymerase
2004 StandoutNature
Approaches to improve the diagnosis and management of infertility
2009
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study
2008
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
2011
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
2004
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
IVF outcome in women with PCOS, PCO and normal ovarian morphology
2009
Results of in vitro fertilization in Italy after the introduction of a new law
2007
Neurosteroid regulation of central nervous system development
2007
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Recurrent implantation failure: definition and management
2013 Standout
Age-related decline in fertility
2003
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization
2008
Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol
2009
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
The Prevention of Ovarian Hyperstimulation Syndrome
2014
Vascular endothelial growth factor in eye disease
2008 Standout
Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization–embryo transfer
2005
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation
2007
Molecular and biological properties of vascular endothelial growth factor
1999
Ultrasound assessment of the polycystic ovary: international consensus definitions
2003
Ovarian stromal echogenicity in women with normal and polycystic ovaries
1999
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
The Role of Vascular Endothelial Growth Factor in Wound Healing
2008 Standout
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Cross-border reproductive care in Belgium
2009 Standout
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Tendon Injury and Tendinopathy
2005 Standout
Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
2015 Standout
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2009
Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)
2003
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
ESHRE guideline: routine psychosocial care in infertility and medically assisted reproduction—a guide for fertility staff: Figure 1
2015 Standout
Role of vascular endothelial growth factor in the regulation of angiogenesis
1999
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome
2000
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
2006 Standout
Does GnRH Agonist Triggering Control Painful Symptom Scores During Assisted Reproductive Technology? A Retrospective Study
2017
VEGF: an update on biological and therapeutic aspects
2000
Angiogenesis as a therapeutic target
2005 StandoutNature
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
Current Concepts in the Polycystic Ovary Syndrome
2001
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor
2001
The use of metformin for women with PCOS undergoing IVF treatment
2006
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Stromal Cell–Derived Factor-1α and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
2005 StandoutNobel
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
2012
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
2016
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Lawrence Engmann being referenced
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
2007
The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study
2007
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes
2008
Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries
1998
Ovarian response in three consecutive in vitro fertilization cycles
2002
Local Side Effects of Subcutaneous and Intramuscular Urinary Gonadotropins for Ovarian Stimulation in In Vitro Fertilization: A Prospective, Randomized Study
1998
Cumulative probability of clinical pregnancy and live birth after a multiple cycle IVF package: a more realistic assessment of overall and age‐specific success rates?
1999
GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis
2016
Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries
1998
Outcome of in vitro fertilization treatment in patients who electively inseminate a limited number of oocytes to avoid creating surplus human embryos for cryopreservation
2005
The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology
1999
GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS
2006
Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome
1999
Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment
1999
Progesterone Regulation of Human Granulosa/Luteal Cell Viability by an RU486-Independent Mechanism
2006